<unk>  is an aromatase inhibitor that is FDA approved for the treatment of breast cancer.   Common adverse reactions include hot flashes, arthralgia, flushing, asthenia, edema, arthralgia, headache, dizziness, hypercholesterolemia, sweating increased, and bone pain.
Letrozole
Anastrozole
Gestrinone
Tamoxifen
Goserelin
Proligeston
Lasofoxifene
Methylestrenolone